Journal Article DZNE-2020-06977

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2019
Springer Science + Business Media B.V Dordrecht [u.a.]

Journal of inherited metabolic disease 42(3), 398-406 () [10.1002/jimd.12049]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Biogenic amines synthesis in phenylketonuria (PKU) patients with high phenylalanine (Phe) concentration is thought to be impaired due to inhibition of tyrosine and tryptophan hydroxylases and competition with amino acids at the blood-brain barrier. Dopamine and serotonin deficits might explain brain damage and progressive neuropsychiatric impairment in adult PKU patients. Ten early treated adult PKU patients (mean age 38.2 years) and 15 age-matched controls entered the study. Plasma and cerebrospinal fluid (CSF) Phe, 5-hydroxyindoleacetic acid (5-HIAA), 5-hydroxytryptophan (5-HTP), 3,4-dihydroxy-l-phenylalanine (l-DOPA) and homovanillic acid (HVA) were analyzed. Voxel-based morphometry statistical nonparametric mapping was used to test the age-corrected correlation between gray matter atrophy and CSF biogenic amines levels. 5-HIAA and 5-HTP were significantly reduced in PKU patients compared to controls. Significant negative correlations were found between CSF 5-HIAA, HVA, and 5-HTP and Phe levels. A decrease in 5-HIAA and 5-HTP concentrations correlated with precuneus and frontal atrophy, respectively. Lower HVA levels correlated with occipital atrophy. Biogenic amines deficits correlate with specific brain atrophy patterns in adult PKU patients, in line with serotonin and dopamine projections. These findings may support a more rigorous Phe control in adult PKU to prevent neurotransmitter depletion and accelerated brain damage due to aging.

Keyword(s): Adult (MeSH) ; Atrophy (MeSH) ; Biogenic Amines: blood (MeSH) ; Biogenic Amines: cerebrospinal fluid (MeSH) ; Case-Control Studies (MeSH) ; Female (MeSH) ; Gray Matter: pathology (MeSH) ; Homovanillic Acid: blood (MeSH) ; Homovanillic Acid: cerebrospinal fluid (MeSH) ; Humans (MeSH) ; Linear Models (MeSH) ; Magnetic Resonance Imaging (MeSH) ; Male (MeSH) ; Middle Aged (MeSH) ; Phenylketonurias: blood (MeSH) ; Phenylketonurias: cerebrospinal fluid (MeSH)

Classification:

Contributing Institute(s):
  1. Parkinson's Disease Genetics (AG Berg)
  2. Parkinson Genetics (AG Gasser)
Research Program(s):
  1. 345 - Population Studies and Genetics (POF3-345) (POF3-345)

Appears in the scientific report 2019
Database coverage:
Medline ; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; IF < 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > TÜ DZNE > TÜ DZNE-AG Gasser
Institute Collections > TÜ DZNE > TÜ DZNE-AG Berg
Public records
Publications Database

 Record created 2020-02-18, last modified 2025-04-15


Fulltext:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)